The 7th Annual CAR–TCR Summit is uniting experts with one common goal of engineering a disease–free world this September. Across this three–day event over one thousand attendees from over three hundred companies will all be coming together to explore discovery through to commercialization to deliver safe, effective and commercially viable CAR and TCR therapies.
September 22 at 12pm ET
INDUSTRY EXPERT PANEL: Manufacturing Track:
"Industry-Academic-Biomanufacturing Partnerships —What Does The Future Hold?"
Join Resilience’s cell therapy leaders Eytan Abraham – VP and Business Head of Cell Therapy, Gene Therapy, and Nucleic Acid Franchises and Bruce Thompson – VP and Technical Head of Cell Therapy Franchise and a panel of industry experts as they lead a thought-provoking discussion on key industry challenges and how we can solve these bottlenecks to future-proof life-saving therapies.
